Taiwan FDA registration cbfaa078304cea82cd2db0a2cf2f2665
BIOPORT CROSSLINK 2.0% Intra-articular Injection
TW: 百樂玻關節內注射劑
Taiwan·Risk Class 3·MD·MAXIGEN BIOTECH INC.·Registered Jul 26, 2022 – Oct 13, 2026ActiveRegistration details
- Analysis ID
- cbfaa078304cea82cd2db0a2cf2f2665
- License Form
- Ministry of Health Medical Device Manufacturing No. 007515
Company information
- Manufacturer
- MAXIGEN BIOTECH INC.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- MAXIGEN BIOTECH INC.
Product details
- Intended Use
- Details are as detailed as approved Chinese instructions
- Product Type (Level 1)
- N Orthopedics
- Product Type (Level 2)
- N0003 Hyaluronic acid implants for the joint cavity
- Import Information
- Produced in Taiwan, China
Dates and status
- Registration Date
- Jul 26, 2022
- Expiry Date
- Oct 13, 2026
About this record
Access comprehensive regulatory information for BIOPORT CROSSLINK 2.0% Intra-articular Injection in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number cbfaa078304cea82cd2db0a2cf2f2665 and manufactured by MAXIGEN BIOTECH INC.. The authorized representative in Taiwan is MAXIGEN BIOTECH INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices